07:28 AM EDT, 05/05/2025 (MT Newswires) -- Ocular Therapeutix ( OCUL ) reported a Q1 net loss Monday of $0.38 per diluted share, narrower than a loss of $0.49 a year earlier.

Analysts polled by FactSet expected a loss of $0.38.

Revenue for the quarter ended March 31 was $10.7 million, compared with $14.8 million a year earlier.

Analysts surveyed by FactSet expected $17 million.

The company's shares were down 8.4% in recent Monday premarket activity.